1Davutoglu V,Yildirim C, Kucukaslan H, et al. Prognostic valueof pleural effusion , CA-125 and NT-proBNP in patients with acutedecompensated heart failure [ J ]. Kardiol Pol,2010 , 68(7)771-778.
2Turk HM, Pekdemir H , Buyukberber S, et al. Serum CA 125levels in patients with chronic heart failure and accompanyingpleural fluid[ J]. Tumour Biol, 2003,24: 172 - 175.
3Kosar F, Aksoy Y, Ozguntekin G, et al. Relationship between cy-tokines and tumour markers in patients with chronic heart failure[J] . Eur J Heart Fail, 2006,8 : 270 - 274.
1D′Aloia A,Faggiano P,Aurigemma G,et al.Serum levels of carbohydrate antigen 125 in patients with chronic heart failure:relation to clinical severity,hemodynamic and Doppler echocardiographic abnormalities,and short-term prognosis[J].J Am Coll Cardiol,2003,41:1805-1811.
2Skórzyńska H,Solski J,Gernand W,et al.Estimation of CA125 concentration in patients with congestive heart failure.Ann Univ Mariae Curie Sklodowska[Med],2004,59(1):261-264.
3Fox R.Elevated CA-125 concentration associated with severe cardiac failure.J Obstet Gynaecol,2004,24(4):471.
4Kosar F,Aksoy Y,Ozguntekin G,et al.Relationship between cytokines and tumour markers in patients with chronic heart failure.Eur J Heart Fail,2006,8(3):270-274.
5Vizzardi E,Nodari S,D′Aloia A,et al.CA125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure.Echocardiography,2008,25(9):955-960.
6Hopman EH,Helmerhorst TJ,Bonfrer JM,et al.Highly elevated serum CA 125 levels in a patient with cardiac failure.Eur J Obstet Gynecol Reprod Biol,1993,48(1):71-73.
7Ngele H,Bahlo M,Klapdor R,et al.CA125 and its relation to cardiac function.Am Heart J,1999,137(6):1044-1049.
8Yoshihiko S,Akio O,Teruyo Y,et al.Application of NT-proBNP and BNP measurement s in cardiac care:a more discerning marker for t he detection and evaluation of heart failure.Eur J Heart Fail,2004,6:295-300.
9O′Hanlon R,O′Shea P,Ledwidge M,et al.The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients.J Card Fail,2007,13(1):50-55.
